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Background: Bovine viral diarrhea virus (BVDV) is a pathogen found worldwide in calves. It can cause significant
economic losses in agriculture. Many BVDV strains have been isolated in China. However, the pathogenesis and
complete gene characteristics of BVDV isolate have yet not been reported in China. Here, a BVDV isolate was
isolated and its pathogenesis and complete genome were studied.
Results: A new isolate of bovine viral diarrhea virus, named JL-1, was isolated from the spleen of a sick cow with
diarrhea using MDBK cell culture. The complete genome of JL-1 is 12,276 nucleotides and contains a 5′-UTR of 382
nucleotides, a 3′-UTR of 188 nucleotides, and a large ORF encoding a polyprotein consisting of 3,901 amino acids.
Genomic comparison and phylogenetic analyses of complete genomic sequence clearly showed that JL-1 fell into
the BVDV-1b subtype. The result of pathogenesis of JL-1 strain showed that all infected calves developed clinical
signs of elevated rectal temperatures, decreased leucopenia, and viral discharge. Viral antigen was detected in
infected animal tissues using immunohistochemistry. Animals in the mock were normal. These results demonstrated
that BVDV JL-1 was a virulent strain.
Conclusions: This is the first study to report the pathogenesis and complete gene characterization of the BVDV
strain in China. This report may set a good foundation for further study of BVDV in China.
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Bovine viral diarrhea virus (BVDV), the etiological agent
of bovine viral diarrhea/mucosal disease, is widespread
and one of the most economically important diseases of
cattle. BVDV-associated diseases can range from clinic-
ally undetectable to severe. They may involve the re-
spiratory, enteric, reproductive, immune, and endocrinee
systems [1,2]. BVDV is a small, enveloped virus with
a single-stranded, positive-sense RNA genome, that
is ~12.5kb in length and contains a 5′- untranslated
region (5′-UTR), a single open reading frame and a
3′-untranslated region (3′-UTR) [3]. According to a
comparison of the 5′-UTR and the Npro- and E2-encoding* Correspondence: tcscsp@126.com; wuhua@sinovetah.com
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unless otherwise stated.sequences, BVDV isolates are divided into two genotypes
(BVDV1 and BVDV2) with several subtypes in each group
[4,5]. The 5′-UTR genomic region provides meaningful
inferences as this region has the highest degree of sequence
conservation and is effectively amplified by RT-PCR [6,7].
BVDV viruses of both genotypes are divided into cytopathic
(cp) and non-cytopathic (ncp) biotypes, based on the ability
of the virus to cause cytopathogenicity in tissuecum culture.
Noncytopathic BVDV is the only biotype that has been
observed clinically or experimentally to cause BVDV
persistent infection. In addition, BVDV are lymphotrophic
and the immunosuppression that follows infection results in
increased severity in secondary infections. The interaction
of BVDV with secondary pathogens is thought to be one of
the contributing factors in bovine respiratory disease com-
plex (BRD) [8-10]. BVDV associated disease can range from
clinically inapparent to severe and can involve the respira-
tory, enteric, reproductive, immune and endocrine systems.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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http://www.virologyj.com/content/11/1/67Infection with BVDV poses a major threat to the cattle
industry. This threat can be minimized through the use
of commercially available BVDV vaccines. BVDV vac-
cines have played a significant role in the prevention of
various clinical disease syndromes associated with BVDV
infections, as well control of the spread of the virus
[11,12]. Now, many countries using vaccination strat-
egies to limit losses due to BVDV. The BVDV 1a and
BVDV2a were the main subtypes in modified live virus
(MLV) and killed viral vaccines. Only one killed vaccine
contains BVDV1b subtype (NY-1 strain) [13]. To evalu-
ate potency of the vaccines, it is unavoidable to need an
appropriate virulent virus strain. BVDV was first isolated
from calves in China 1980 [14,15]. To date, many BVDV
strains were isolated in china, the BVDV circulating in
Chinese calves is mainly BVDV1b [16,17]. However, there
are no commercial BVDV vaccines in the market of China
at present, and the pathogenic BVDV isolate was not re-
ported previously in China. At the basic biology level, the
study of virulence variation is important to understanding
the mechanisms behind pathology [18]. The purpose of
this work was isolate and examine the virulence of BVDV
JL-1 strain, which would contributes to the research of this
disease and development of BVDV vaccine candidate.
Results
Isolation and identification
Homogenates of tissues samples were cultured and pas-
saged in MDBK cells, and no cytopathic effects (CPE) was
observed in MDBK cell after 4 passages. The presence of
BVDV isolates in MDBK cells has been confirmed by
FITC-labeled BVDV antibody. The specific green signals of
FITC were detected in the infected group, and the mock
group had no fluorescence signals (Figure 1), then one viral
isolate was obtained and named strain BVDV JL-1.
Sequence and phylogenetic analysis of the complete
genome
The complete genome of JL-1 was 12,276 nucleotides in
length. It contains 5′-UTR of 382 nucleotides, a 3′-UTRFigure 1 IFA identification of virus isolate cultured in MDBK cells. A. Noof 188 nucleotides, and a large ORF encoding a polypro-
tein consisting of 3,901 amino acids. The complete gen-
omic sequence of JL-1 has been submitted to GenBank
under accession number KF501393. The nucleotide and
amino acid sequences of the structural and nonstruc-
tural proteins of JL-1 were most similar to those of
strain CP7 (a prototype of BVDV-1b). The nucleotide
identity of the complete genome was 67.6–93.2% be-
tween JL-1 isolate and BVDV1, BVDV2, and BVDV3
strains. A 93.2% identity of JL-1 isolate and CP7 genome
was observed. The similarity between JL-1 isolate and
other BVDV strains with respect to deduced amino acids
ranged from 72.4–95.3%. A phylogenetic tree was con-
structed by comparing the E2 sequence of JL-1 and
other pestiviruses obtained from GenBank. These results
of the analysis showed that the JL-1 strain was classified
as BVDV1b with 100% bootstrap value (Figure 2).
Pathogenesis of BVDV JL-1 strain
All 5 calves inoculated with BVDV JL-1 developed mod-
erate clinical signs associated with BVDV infection, in-
cluding depression, fever, leucopenia, and viremia. The
control calves were normal.
The rectal temperatures of calves were measured daily
from day −1 (before inoculation) to day 14 (after inocu-
lation). All treated calves (5/5) showed elevated rectal
temperatures, with peak temperatures appearing on days
7–8 after inoculation. Two calves had rectal tempera-
tures higher than 40.0°C on several days. The control
calves did not develop fevers at any point in time after
treatment (Figure 3A).
White blood cell counts of treated calves started de-
creasing from day 2 after inoculation. The mean WBC
counts for the control group dropped significantly from
9.8×1000 per mm3 on day 0 to 5.9×1000 per mm3 on
days 4 and 6 after inoculation, a decrease of approxi-
mately 40% (Figure 3B). The mean WBC counts in the
control group did not decrease after inoculation, and
they were significantly higher (P<0.05) than that of the
control group on days 2–8 post-inoculation.n-infected MDBK cells; B. BVDV JL-1 Isolate-infected MDBK cell (200×).
Figure 2 Phylogenetic tree analysis of the E2 was created using the nucleotide sequences of the JL-1 isolate. The phylogenetic tree
was prepared using the Neighbor-Joining method and bootstrap testing. Numbers over branches indicate the percentage of 1,000 bootstrap
replicates that support each phylogenetic branch.
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http://www.virologyj.com/content/11/1/67Nasal swab samples were collected from all calves
from day −1 to day 14 after inoculation and viral shed-
ding was assessed. All treated calves shed BVDV on
multiple days from day 4 to day 10 after inoculation.
Buffy-coat samples were collected from the blood taken
every other day to day 14 after inoculation. The isolation
of the virus from the blood was conducted to assess
viremia in the calves. Results showed that all treated
calves had viremia and BVDV was isolated from blood
from different cows on days 4–10. Sera obtained before
inoculation with BVDV JL-1 and on day 14 was sub-
jected to neutralization testing. Results showed that all
of the virus-infected calves developed virus-neutralizing
antibodies by day 14 (Table 1).
The primary morphological changes were observed in
the digestive tract and lymphoid tissue. Briefly, there was
a little reduction the thickness of the intestine and mildFigure 3 The clinical observation following inoculated with BVDV JL-1
cell counts B. The error bars represent standard deviation. Statistical valueshyperemia, and edema of the small intestinal mucosa
and swelling and hemorrhage of mesenteric lymph
nodes and the gut-associated lymphoid tissue were
observed. The small intestine villi showed mild
hemorrhage and shedding (Figure 4A). Lymphoid deple-
tion was the most prominent within the germinal
centers of follicles of the lymphoid node and in the peri-
arteriolar lymphoid sheath (Figure 4B). In IHC staining,
the distribution of BVDV-specific antigen was consist-
ently found in the epithelia of the intestines and in
mononuclear cells randomly scattered in splenic red
pulp (Figure 4C and D). No pathological damage was
found in the control calves.
Discussion
In this study, a new BVDV JL-1 strain was isolated from
calves afflicted with BVD, a recently discovered BVDVvirus. A. elevated rectal temperatures; and decrease of white blood
are *p<0.05 and **p<0.01.
Table 1 Detection of virus isolation and Serum neutralization antibody titres from calves experimentally inoculated
with BVDV JL-1 strain
Animal no. No. of days that samples virus was isolated/total no. SN titres
to BVDVVirus isolation (buffer coat) Virus isolation (Nasal swab) RT-PCR (Nasal swab)
Calve 170144 2/8 3/15 4/15 16
Calve 170115 2/8 4/15 6/15 32
Calve 170166 3/8 5/15 7/15 64
Calve 183117 3/8 3/15 5/15 48
Calve 183155 1/8 3/15 5/15 8
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http://www.virologyj.com/content/11/1/67present in northeastern China. The identification of the
isolate has been confirmed by IFA. Many other studies
have demonstrated that the BVDV-1b subgenotype is
the most common of the BVDV-1 field isolates. The
trend of relative increase in BVDV-1b isolates was found
not only during comparison of different geographic re-
gions but also during comparison of the isolates found
over the past 20years in one diagnostic laboratory
[19,20]. In this study, the phylogenetic relationships
among BVDV JL-1 and other BVDV wild-type strains
from GenBank were clarified. Genetic and phylogenetic
analysis showed that the virus BVDV JL-1 belonged to
BVDV1b, and a high degree of identity was detected
among all studied wild-type strains in China.
The present pathogenesis study was performed upon
conventionally reared calves. Results indicated thatFigure 4 The pathology detection following inoculated with BVDV JL
showing the significantly wided periarterial lymphatic sheath and lymphoc
and shedding in the small intestine villi (100×). Immunohistochemistry (IHC
mononuclear cells randomly scattered in splenic red pulp (200×); D. virus aBVDV JL-1 can induce mild clinical disease. Clinical
presentation after infection with BVDV JL-1 was similar
to that observed after infection with the BVDV NY-1
strain. Clinical manifestations included mild short-
term pyrexia (basal temperatures between 39.2 and
40.0°C for 1–3days), pronounced and prolonged fe-
brile response, pronounced reduction in circulating
white blood cells (>40%), and viral excretion in the
buffy coat. All of the virus-infected calves developed
virus-neutralizing antibodies by day 14. Strain NY-1
belongs to the BVDV1 pestivirus species (subgenotype
BVDV1b). It is the first noncytopathic BVDV strain to
be isolated. In recent years, the NY-1 strain has be-
come an accepted laboratory reference strain. It has
also been offered as a challenge strain for vaccine effi-
cacy studies [18].-1. Histopathology appearances of H&E-stain (A and B), A. spleen,
ytes depletion in red pulp (100×); B. intestines: showing hemorrhage
) detection of BVDV antigen (C and D). C. spleen, virus antigens in
ntigens in epithelium of intestines (200×).
Zhang et al. Virology Journal 2014, 11:67 Page 5 of 7
http://www.virologyj.com/content/11/1/67The clinical symptoms observed in calves from which
BVDV JL-1 was isolated mainly showed anorexia, diar-
rhea, dehydration, and marasmus. The present patho-
genesis study, which was performed upon BVDV JL-1,
only mild clinical signs associated with BVDV infection
were observed. These included depression, fever, leuco-
penia, and viremia. None of the treatment calves showed
diarrhea. This might be related to the immune state and
age of experimental animals. In this report, the BVDV
JL-1 virus isolates were confirmed to be free of contam-
ination by viruses, mycoplasmas, bacteria, and fungi.
The experimental animals were 6 to 9 months old and
immunocompetent. No secondary infections occurred
during the animal experiment. Histopathological obser-
vation showed lymphoid depletion and shedding of the
villi of the small intestine. If the treatment calves experi-
enced a secondary infection at that time, the results led
to an exacerbation of the inflammatory response and to
the development of more intense clinical symptoms and
lesions than those observed in healthy animals [21].
Various authors have demonstrated that BVDV can in-
duce lymphopenia and has a range of effects on the im-
mune response. These can allow secondary infection to
take place [22,23].
Ever since the first isolation of BVDV in 1980, no ef-
fective measures have been developed to control the
spread of BVDV in China. This is the first report of a
pathogenic BVDV strain in China, here called BVDV
JL-1. It is an NY-1 strain, so infection of immunocompe-
tent adult calves can cause clinical manifestations. These
findings may contribute to the development of a vaccine
for the prevention and control of BVDV in China.
Conclusions
In this study, a BVDV JL-1 strain was successfully iso-
lated from cattle in china. Genomic comparison and
phylogenetic analyzes showed that JL-1 fall into BVDV-
1b subtype, the predominant genotype in China. Patho-
genic assay show its remains virulent and can be used as
a BVDV challenge virus to evaluate the efficacy of BVDV
vaccines. This report will be a good beginning for fur-
ther studies on BVDV in china.
Methods
Virus isolation
Field samples came from calves at field of Jilin province
(China), which clinical symptoms showed anorexia, diar-
rhea, dehydration and marasmus. The tissue samples
were collected from the necropsies of one calve and then
stored at −80°C. The virus isolation was conducted as
described previously [24,25]. Briefly, Homogenates con-
taining 1g of each tissue (including spleen, lung, thymus,
intestine and Lymph node) samples and 10 mL of
Dulbecco’s modified Eagle’s medium with antibioticswere sonicated and centrifuged. A monolayer of MDBK
cell was infected with the homogenates in a 24-well cul-
ture plate. The cell cultures were frozen and thawed
three times and passaged two to three times at five days
interval. The every passage of MDBK cultures were
observed for 5days with presence or absences of CPE
recorded.
RT-PCR detection and complete genomic sequence
analysis
Total RNA was extracted from field tissue samples and
cell culture fluids of virus isolates using TRIZOL
(Invitrogen, China) according to the manufacturer’s
instructions. The extraction was accomplished using
250 μl of samples and 750 μl of TRIZOL. The RNA was
resuspended in 30 μl DEPC-treated water. The extracted
RNA was reverse-transcribed using the M-MLV Reverse
Transcriptase Kit (Invitrogen, USA) as specified by the
manufacturer. Twelve primer sets were designed to amplify
overlapping regions of the complete BVDV genome. The
amplified fragments were harvested and cloned into
pMD–18T vector (TaKaRa, China). Three recombinant
clones were submitted to DNA sequencing (Invitrogen
Biotech, Beijing, China). The retrieved sequences were
edited and trimmed with the EditSeq program in the
DNASTAR software. Clustal W was used to align the
nucleotide sequences. Phylogenetic analysis was done
by the distance-based clustal W method using software
MEGA 4.1.
Immunofluorescence assay (IFA)
A 96 well microtitre plate (Costar, NY, USA) was seeded
with MDBK cell in DMEM with 8% ES, and cultivated at
37°C in 5% CO2 overnight until 70-80% confluence. The
cultures were then inoculated with 20-fold diluted field
BVDV isolates at 3 passage. The uninfected cultures in
left rows of the plate were taken as the negative controls.
After 72hrs incubation in 37°C, 5% CO2 atmosphere, the
plate was fixed in 80% cold acetone/methanol, and then
washed with PBS, FITC-conjugated Anti-Bovine Viral
Diarrhea Virus (BVDV) polyclonal antiserum. (VMRD,
USA) was added to the plate, and then followed by
30 min incubation in a 37°C humid box. After 3 times
washes with PBS, a 50% glycerol in PBS was added to
each well. Two infected wells were treated as a positive
control to confirm viral growth. Fluorescence signal was
observed using an fluorescence inverted microscope
(Zeiss Axioskop-40, Germany).
Infection of animals
Ten healthy calves (6 to 9-month-old) were obtained
from a calve farm that was negative for BVDV infec-
tions. All animals were confirmed to be free of BVDV,
IBRV,BPI3, Mycoplasma bovis infections using enzyme-
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tion of antibodies against BVDV, IBRV, BPI3, or M. bovis
(Idexx Labs Inc., American) and by reverse transcription-
PCR (RT-PCR) or PCR for viral nucleic acid detection
[26-28]. All animal work and experimental procedures
were conducted with an approval of Institutional Animal
Care and Use Committee of Jinlin University, China. The
10 calves were divided randomly into treatment group and
control group, with 5 animals in each group. Each calve of
the treatment group was inoculated intranasally (IN) with
~6×107.0 tissue culture infective doses (TCID50) of BVDV
JL-1 virus. The animals in control group were inoculated
IN with DMEM. All animals were monitored daily for clin-
ical signs as described previously [29]. Clinical assessments
were made at the same time each morning by investigators
who were blinded to the treatment groups. Clinical signs
included depression, nasal discharge, diarrhea, coughing
and rectal temperatures. EDTA-blood samples from calves
were collected at days−2 to 0 prior to inoculation and days
2, 4, 6, 8, 10, 12, 14 post-inoculation (dpi) and used to
count white blood cells. Additionally, at day 0, 2, 4, 6, 8, 10,
12, 14 post-inoculation (dpi), heparin blood was taken for
buffy-coat preparations to test for viremia in the challenged
calves. Deep nasal swab specimens were obtained from one
day prior to challenge through 14 days post inoculation.
The procedure to isolate BVDV from buffy-coat samples
was conducted as described previously [30]. Sera obtained
before inoculation with BVDV JL-1 and on day 14, Serum
sample were tested for neutralizing antibodies to
BVDV JL-1 using standard microtitration procedures [31].
Two calves out from each group were necropsied at
14 DPI, and their tissue samples were collected and
fixed in 10% neutral buffered formalin and processed for
histopathological examination following hematoxylin and
eosin (H&E) staining and immunohistochemistry.
The two groups (treatment and control) were analyzed
and compared with respect to the primary clinical signs
including rectal temperature, nasal and ocular dis-
charges,diarrhea, leukopenia and virus shedding, using
GraphPad Prism (version 4.0) software. The level of sta-
tistically significant difference was set at p<0.05.
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